Ethical implications of time frames in a randomized controlled trial in acute severe traumatic brain injury

Progress in Brain Research

Volumn 161, Issue , 2007, Pages 243-250

  Kompanje, Erwin J O ^a   Maas, Andrew I R ^a   Slieker, François J A ^a   Stocchetti, Nino ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

deferred consent; emergency trial; informed consent; traumatic brain injury

Indexed keywords

DEXANABINOL;

ADULT; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY CARE; ETHICS; FEMALE; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SAFETY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; TIME; TRAUMATIC BRAIN INJURY;

ACUTE DISEASE; ADULT; BRAIN INJURIES; CLINICAL TRIALS, PHASE III; EUROPE; FEMALE; HOSPITALIZATION; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS; THIRD-PARTY CONSENT; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34347326048     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(06)61017-0     Document Type: Review

References (32)

1. Annane D., Outlin H., Fisch C., and Bellissant E. The effect of waiving consent on enrolment in a sepsis trial. Intensive Care Med. 30 (2004) 632-637
2. Blixen C.E., and Agich G.J. Stroke patients preferences and values about emergency research. J. Med. Ethics 31 (2005) 608-611
3. Clifton G.L., Knudson P., and McDonald M. Waiver of consent in studies of acute brain injury. J. Neurotrauma 19 (2002) 1121-1126
4. Coppolino M., and Ackerson L. Do surrogate decision makers provide accurate consent for intensive care research?. Chest 119 (2001) 603-612
5. CRASH trial management group. Research in emergency situations: with or without relatives consent. Emerg. Med. J. 21 (2004) 703
6. Cuttini M. Proxy informed consent in pediatric research: a review. Early Hum. Dev. 60 (2000) 89-100
7. European Union. (2001) Directive 2001/20/EC of the European Parliament and the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off. J. Eur. Comm., L121/34.
8. Freeman D.B. Safeguarding patients in clinical trials with high mortality rates. Am. J. Crit. Care Med. 164 (2001) 190-192
9. Harth S.C., and Thong Y.H. Parental perceptions and attitudes about informed consent in clinical research involving children. Soc. Sci. Med. 40 (1995) 1573-1577
10. Hoff J.T. Cerebral protection. J. Neurosurg. 65 (1986) 579-591
11. Hsieh M., Dailey M.W., and Callaway C.W. Surrogate consent by family members for out-of-hospital cardiac arrest research. Acad. Emerg. Med. 8 (2001) 851-853
12. Kompanje E.J.O., Maas A.I.R., Hilhorst M.T., Slieker F.J.A., and Teasdale G.M. Ethical considerations on consent procedures for emergency research in severe and moderate traumatic brain injury. Acta Neurochir. (Wien.) 147 (2005) 633-640
13. Kompanje E.J.O., and Maas A.I.R. 'Treat first, ask later?' Emergency research in acute neurology and neurotraumatology in the European Union. Intensive Care Med. 30 (2004) 168-169
14. Kompanje E.J.O., and Maas A.I.R. Is the Glasgow Coma Scale score protected health information? The effect of new United States regulations (HIPAA) on completion of screening logs in emergency research trials. Intensive Care Med. 32 (2006) 313-314
15. Lemaire F. Waiving consent for emergency research. Eur. J. Clin. Invest. 35 (2005) 287-289
16. Lewis R.J., Berry D.A., Cryer H., Fost N., Krome R., Washington G.R., Houghton J., Blue J.W., Bechhofer R., Cook T., and Fisher M. Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial. Ann. Emerg. Med. 38 (2001) 397-404
17. Liddell K., Chamberlain D., Menon D.K., Bion J., Kompanje E.J.O., Lemaire F., Druml C., Vrhovac B., Wiedermann C.J., and Sterz F. The European Clinical Trial Directive revisited: the VISEAR recommendations. Resuscitation 69 (2006) 9-14
18. Liddell K., Kompanje E.J.O., Lemaire F., Vrhovac B., Menon D.K., Bion J., Chamberlain D., Wiedermann C.J., and Druml C. Recommendations in relation to the EU Clinical Trials Directive and medical research involving incapacitated adults. Wien. Klin. Wochenschr. 118 (2006) 183-191
19. Luce J.M. Is the concept of informed consent applicable to clinical research involving critically ill patients? Crit. Care Med. 31 Suppl (2003) S153-S160
20. Maas A.I.R., Kompanje E.J.O., Slieker F.J.A., and Stocchetti N. Differences in completion of screening logs between Europe and the United States in an Emergency phase III trial resulting from HIPAA requirements. Ann. Surg. 241 2 (2005) 382-383
21. Maas A.I.R., Marmarou A., Murray G.D., and Steyerberg E.W. Clinical trials in traumatic brain injury: current problems and future solutions. Acta Neurochir. 89 (2004) 113-118
22. Maas A.I.R., Murray G., Henney H., Kassem N., Legrand V., Mangelus M., Muizelaar J.P., Stocchetti N., Knoller N., and on behalf of the Pharmos TBI Investigators. Efficacy and safety of dexanabinol in sever traumatic brain injury: results of a phase III randomized placebo controlled clinical trial. Lancet Neurol. 5 (2006) 38-45
23. Maas A.I.R., Steyerberg E.W., and Murray G.D. Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations. Neurosurgery 44 (1999) 1286-1298
24. Mason S.A., and Allmark P.J. Obtaining informed consent to neonatal randomised controlled trials: interviews with parents and clinicians in the Euricon study. Lancet 356 (2000) 2045-2051
25. McClure K.B., Delorio N.M., Gunnels M.D., Ochsner M.J., Biros M.H., and Schmidt T.A. Attitudes of emergency department patients and visitors regarding emergency exception from informed consent in resuscitation research, community consultation and public notification. Acad. Emerg. Med. 10 (2003) 352-359
26. McGarry L.J., Thompson D., Millham F.H., Cowell L., Snyder P.J., Lenderking W.R., and Weinstein M.C. Outcomes and costs of acute treatment of traumatic brain injury. J. Trauma 53 (2002) 1152-1159
27. Roupie E., Santin A., Boulme R., Wartel J.S., Lepage E., Lemaire F., Lejonc J.L., and Montagne O. Patients preferences concerning medical information and surrogacy: results of a prospective study in a French emergency department. Intensive Care Med. 26 (2000) 52-56
28. Shohami E. Long-term effect of HU-211, a novel competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res. 674 (1995) 55-62
29. Silverman H.J., Druml C., Lemaire F., and Nelson R. The European Union Directive and the protection of incapacitated subjects in research: an ethical analysis. Intensive Care Med. 30 (2004) 1723-1729
30. Sugarman J. Is the emperor really wearing new clothes? Informed consent for acute coronary syndromes. Am. Heart J. 140 (2000) 2-3
31. Tu J.V., Willison D.J., Silver F.L., Fang J., Richards J.A., Laupacis A., and Kapral M.K. Impracticability of informed consent in the registry of the Canadian stroke network. NEJM 350 (2004) 1414-1421
32. Williams B.F., French J.K., and White H.D. Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study. Lancet 361 (2003) 918-922